Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 2/20 | 0.56 |
| ▸ | MC5R | P33032 | 2/20 | 0.56 |
| ▸ | MC3R | P41968 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16151768 | 0.97 | MC4R (0.54) | MC4RMC5RMC3RBCHELTA4H | |
| Hydrochloric Acid SCHEMBL29778308 | 0.96 | MC4R (0.52) | MC4RMC5RMC3RBCHELTA4H | |
| SCHEMBL25047737 | 0.89 | MC4R (0.59) | MC4RMC5RMC3RBCHEKDM4E | |
| SCHEMBL25047684 | 0.83 | KDM4E (0.60) | MC4RMC5RMC3RBCHELTA4H | |
| SCHEMBL3025568 | 0.80 | LTA4H (0.62) | MC4RMC5RMC3RBCHELTA4H | |
| SCHEMBL16264603 | 0.80 | BCHE (0.59) | MC4RMC5RMC3RBCHECHRM2 | |
| SCHEMBL16429181 | 0.79 | MC4R (0.39) | MC4RMC5RMC3RLTA4HDRD4 | |
| SCHEMBL16151783 | 0.79 | MC4R (0.58) | MC4RMC5RMC3RSMN1; SMN2MAOA | |
| SCHEMBL16264586 | 0.79 | MC4R (0.57) | MC4RMC5RMC3RSMN1; SMN2MAOA | |
| SCHEMBL16429310 | 0.79 | MARS1 (0.49) | BCHELTA4HKDM4EALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180125070-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | THE UNIVERSITY OF UTAH | 2018-05-10 | — | — | US | disclosed |
| US-9220267-B2 | Methods of use comprising a biocidal polyamine | CURZA GLOBAL, LLC (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150038705-A1 | METHODS OF USE COMPRISING A BIOCIDAL POLYAMINE | CURZA GLOBAL, LLC | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038705-A1 | METHODS OF USE COMPRISING A BIOCIDAL POLYAMINE | SRM, SMOX, SMS | MC4R 4842/4885MC5R 4508/4885MC3R 4645/4885 |
| US-20180125070-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMOX, SMS | MC4R 4831/4885MC5R 4420/4885MC3R 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.